aTyr Pharma | LIFE - Ordinary Share Capital


aTyr Pharma reported $16.65M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Ardelyx USD 244.35M 1.38M Dec/2025
aTyr Pharma USD 16.65M 81.34M Dec/2025
Biogen USD 146.7M 200K Sep/2025
Bristol-Myers Squibb USD 2.04B 1.74B Sep/2025
Cipla INR 807.77M 807.43M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1.02M Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Curis USD 12.93M 12.87M Dec/2025
Galapagos EUR 65.9M 0 Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Grifols EUR 680.58M 846.11K Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
United Therapeutics USD 43.64M 740K Dec/2025
Xoma USD 87K 1000 Jun/2024